PolyPeptide Group AG (SWX:PPGN)
Switzerland
· Delayed Price · Currency is CHF 24.45
+0.70 (2.95%)
At close: Mar 9, 2026
PolyPeptide Group AG Revenue
PolyPeptide Group AG had revenue of 167.10M EUR in the half year ending June 30, 2025, with 26.75% growth. This brings the company's revenue in the last twelve months to 368.85M, up 13.99% year-over-year. In the year 2024, PolyPeptide Group AG had annual revenue of 336.79M with 5.13% growth.
Revenue (ttm)
368.85M EUR
Revenue Growth
+13.99%
P/S Ratio
2.27
Revenue / Employee
263.46K EUR
Employees
1,400
Market Cap
783.55M CHF
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.94B |
| Galderma Group AG | 4.16B |
| Lonza Group AG | 6.53B |
| Tecan Group AG | 906.60M |
| Aevis Victoria | 955.96M |
| SKAN Group AG | 332.13M |
| Kuros Biosciences AG | 103.35M |
PolyPeptide Group AG News
- 7 weeks ago - PolyPeptide Reports Strong Preliminary 2025 Results With Higher Revenue And Profit - Nasdaq
- 7 weeks ago - PolyPeptide Group AG (PLYGF) Reports FY Revenue of EUR 389M - GuruFocus
- 3 months ago - Lupin subsidiary forms long-term strategic alliance with PolyPeptide Group to strengthen global peptide supply chain - Business Upturn